Patrick Tam, PhD

Clinical Development Lead

image

Novateur Advisor Since

2019

Field

Preclinical & Clinical Development

Specialties

Therapeutics

"We love using our know-how and experience to help clients move their projects forward in the clinic and beyond.”

Patrick Tam, PhD
Clinical Development Lead

Dr. Patrick Tam is an expert nonclinical development scientist, with over 20 years of industrial experience and a track record of successful completion of preclinical, IND, and NDA projects. Patrick has expertise across all aspects of early-phase drug development, including PK/ADME, pharmacology, toxicology, bioanalytical method development and validation, and clinical pharmacology, as well as Phase I-II clinical program development and operations. He has extensive knowledge in the design and management of Phase I clinical studies, including drug-drug interaction, ethnic bridging, bioavailability, and metabolism/excretion/mass balance, and has authored the nonclinical sections of regulatory filings. Most recently, Patrick held the position of Senior Director at Aquinox Pharmaceuticals, with prior positions as Director, Nonclinical Development at Forbes Medi-Tech and Senior Scientist, Preclinical at Inex Pharmaceuticals. Patrick has contributed to 17 peer-reviewed publications.

Novateur
Newsletter

Subscribe to our newsletter for access to latest updates.

Resource
Databases

Access Novateur news as well as FDA and Expert Databases.

Relevant
Events

Check out conferences and events we are attending!

Article
Features

Read articles by our team! Featured in BioteCanada Insights and Nature among others.